Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit

被引:502
作者
AlvarezLerma, F
Pellus, AM
Sanchez, BA
Ortiz, EP
Jorda, R
Barcenilla, F
Maravi, E
Galvan, B
Palomar, M
Serra, J
Bermejo, B
Mateu, A
Quintana, E
Palacios, MS
Giral, R
Gonzalez, V
Lerma, FA
Mesa, JL
Melgarejo, JA
Martinez, J
Insausti, J
Olaechea, P
Chanovas, M
Gilabert, A
Junquera, C
Valles, J
Palacios, F
Calvo, R
Mesalles, E
Nava, J
Santos, A
Armengol, S
Marzo, D
机构
[1] HOSP VIRGEN ARRITXACA, MURCIA, SPAIN
[2] HOSP GEN ALICANTE, ALICANTE, SPAIN
[3] HOSP TORRECARDENAS, ALMERIA, SPAIN
[4] HOSP SON DURETA, PALMA DE MALLORCA, SPAIN
[5] HOSP ARNAU VILANOVA, LLEIDA, SPAIN
[6] HOSP VIRGEN CAMINO, PAMPLONA, SPAIN
[7] HOSP LA PAZ, MADRID, SPAIN
[8] HOSP GEN VALLE HEBRON, BARCELONA, SPAIN
[9] HOSP PRINCIPES ESPANA, HOSP LLOBREGAT, BARCELONA, SPAIN
[10] HOSP SANTA CRUZ & SAN PABLO, BARCELONA, SPAIN
[11] HOSP INSULAR LAS PALMAS, Las Palmas Gran Canaria, SPAIN
[12] HOSP GEN YAGUE, BURGOS, SPAIN
[13] HOSP MIGUEL SERVET, ZARAGOZA, SPAIN
[14] HOSP RIO CARRION, PALENCIA, SPAIN
[15] HOSP SANTA MARIA ROSELL, CARTAGENA, SPAIN
[16] CLIN PLATON, BARCELONA, SPAIN
[17] HOSP NAVARRA, PAMPLONA, SPAIN
[18] HOSP GALDAKANO, VIZCAYA, SPAIN
[19] HOSP VIRGEN DE LA CINTA, TARRAGONA, SPAIN
[20] CTR HOSP MANRESA, BARCELONA, SPAIN
[21] HOSP GEN SEGOVIA, SEGOVIA, SPAIN
[22] HOSP ESPERANZA, BARCELONA, SPAIN
[23] HOSP GEN ELCHE, ELCHE, VALENCIA, SPAIN
[24] HOSP PUERTO SAGUNTO, VALENCIA, SPAIN
[25] HOSP GERMANS TRIAS & PUJOL, BADALONA, SPAIN
[26] HOSP MUTUA TERRASSA, BARCELONA, SPAIN
[27] HOSP PROV, SANTIAGO DE COMPOSTELA, SPAIN
[28] QUINTA SALUD ALIANZA, BARCELONA, SPAIN
[29] HOSP CREU ROJA DE BARCELONA, HOSP LLOBREGAT, BARCELONA, SPAIN
关键词
nosocomial pneumonia; empiric antibiotic therapy; intensive care unit; modification of antibiotic treatment; attributable mortality;
D O I
10.1007/BF01712153
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the frequency of and the reasons for changing empiric antibiotics during the treatment of pneumonia acquired in the intensive care unit (ICU). Design: A prospective multicenter study of 1 year's duration. Setting: Medical and surgical ICUs in 30 hospitals all over Spain. Patients. Of a total of 16 872 patients initially enrolled into the study, 530 patients developed 565 episodes of pneumonia after admission to the ICU. Results: Empiric antibiotics were administered in 490 (86.7%) of the 565 episodes of pneumonia. The antimicrobials most frequently used were amikacin in 120 cases, tobramycin in 110, ceftazidime in 96, and cefotaxime in 96. Monotherapy was indicated in 135 (27.6%) of the 490 episodes, a combination of two antibiotics in 306 episodes (62.4%), and a combination of three antibiotics in 49 episodes (10%). The empiric antibiotic treatment was modified in 214 (43.7%) cases because of isolation of a microorganism not covered by treatment in 133 (62.1%) cases, lack of clinical response in 77 (36%), and development of resistance in 14 (6.6%). Individual factors associated with modification of empiric treatment identified in the multivariate analysis were microorganism not covered (relative risk (RR)) 22.02; 95% confidence interval (CI) 11.54 to 42.60; p < 0.0001), administration of more than one antimicrobial (RR 1.29; 95% CI 1.02 to 1.65; p = 0.021), and previous use of antibiotics (RR 1.22; 95% CI 1.08 to 1.39; p = 0.0018). Attributable mortality was 16.2% in patients with appropriate initial therapy and 24.7% in patients with inappropriate treatment (p = 0.034). Conclusions. A high percentage of patients (43.7%) required modification of empiric antibiotic treatment for pneumonia acquired in the ICU. In 62.1% of cases the main reason for changing antibiotic treatment was inadequate antibiotic coverage of microorganisms. Attributable mortality was significantly higher in patients-with inappropriate initial antibiotic therapy. Rapid and accurate diagnostic methods are needed to initiate appropriate antibiotic treatment as soon as pneumonia is suspected.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 32 条
[1]  
ACAR JF, 1985, REV INFECT DIS, V7, pS513
[2]  
ALVAREZ F, 1991, REV ESP QUIM, V4, P37
[3]  
ALVAREZ F, 1993, INFECCIONES UNIDADES, P49
[4]   DIAGNOSIS OF NOSOCOMIAL BACTERIAL PNEUMONIA IN ACUTE, DIFFUSE LUNG INJURY [J].
ANDREWS, CP ;
COALSON, JJ ;
SMITH, JD ;
JOHANSON, WG .
CHEST, 1981, 80 (03) :254-258
[5]   ENDOBRONCHIAL PH - RELEVANCE TO AMINOGLYCOSIDE ACTIVITY IN GRAM-NEGATIVE BACILLARY PNEUMONIA [J].
BODEM, CR ;
LAMPTON, LM ;
MILLER, DP ;
TARKA, EF ;
EVERETT, ED .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (01) :39-41
[6]   DIAGNOSIS OF NOSOCOMIAL PNEUMONIA IN INTENSIVE-CARE UNIT PATIENTS [J].
CHASTRE, J ;
FAGON, JY ;
DOMART, Y ;
GIBERT, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (01) :35-39
[7]   INVASIVE DIAGNOSTIC TESTING SHOULD BE ROUTINELY USED TO MANAGE VENTILATED PATIENTS WITH SUSPECTED PNEUMONIA [J].
CHASTRE, J ;
FAGON, JY .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (02) :570-574
[8]   INCIDENCE AND RISK-FACTORS OF PNEUMONIA ACQUIRED IN INTENSIVE-CARE UNITS - RESULTS FROM A MULTICENTER PROSPECTIVE-STUDY ON 996 PATIENTS [J].
CHEVRET, S ;
HEMMER, M ;
CARLET, J ;
LANGER, M .
INTENSIVE CARE MEDICINE, 1993, 19 (05) :256-264
[9]   EFFECT OF INTENSIVE-CARE UNIT NOSOCOMIAL PNEUMONIA ON DURATION OF STAY AND MORTALITY [J].
CRAIG, CP ;
CONNELLY, S .
AMERICAN JOURNAL OF INFECTION CONTROL, 1984, 12 (04) :233-238
[10]   NOSOCOMIAL PNEUMONIA IN VENTILATED PATIENTS - A COHORT STUDY EVALUATING ATTRIBUTABLE MORTALITY AND HOSPITAL STAY [J].
FAGON, JY ;
CHASTRE, J ;
HANCE, AJ ;
MONTRAVERS, P ;
NOVARA, A ;
GIBERT, C .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :281-288